InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Glaxosmithkline Plc. Officer active across 4 companies, notably Innoviva, Inc.. Cumulatively, 3 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €320.7m. Activity tracked since 20 May 2021. The latest transaction was disclosed on 20 May 2021 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Glaxosmithkline Plc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
1,505 sharesCommon StockSEC:0001387131-21-007179:0
30,253,189 sharesCommon StockSEC:0001387131-21-006822:0
32,005,260 shares@ US$12.25100.0% of flowCommon StockSEC:0001387131-21-006039:0
3 of 3 declarations
About Glaxosmithkline Plc
GLAXOSMITHKLINE PLC is a director and insider, involved with Innoviva, Inc., Lyell Immunopharma, Inc., and CVRx, Inc.
